2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciucci, A; De Stefano, I; Gallo, D; Mancuso, M; Meco, D; Riccardi, R; Saran, A; Scambia, G; Travaglia, D; Zannoni, GF | 1 |
| Borra, F; Gallo, D; Giardullo, P; Leonardi, S; Majo, VD; Mancuso, M; Pasquali, E; Pazzaglia, S; Prisco, MG; Saran, A; Scambia, G; Stefano, ID; Tanori, M | 1 |
2 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Arachnoidal Cerebellar Sarcoma, Circumscribed
| Article | Year |
|---|---|
Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?
Topics: Animals; Apoptosis; Biomarkers, Tumor; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Dihydrotestosterone; Estradiol; Estrogen Receptor beta; Female; Humans; Male; Medulloblastoma; Mice; Nitriles; Phenols; Pyrazoles; Sex Characteristics; Signal Transduction | 2014 |
The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways.
Topics: Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Estrogen Receptor beta; Female; Immunohistochemistry; Male; Medulloblastoma; Mice; Nitriles; Propionates; Signal Transduction | 2011 |